“…Liver glycogen contents were significantly decreased ( p < 0.05). In therapeutic group, L. casei Zhang administration possessed improved glucose tolerance ( p < 0.05), which were associated with increased osteocalcin level ( p < 0.01), improved intestinal bile acids secretion ( p = 0.060), decreased serum MDA levels ( p < 0.05) and upregulation of LXR-α, PPAR-γ and AdipoR2 gene expression.[64] | Lactobacillus reuteri GMNL-263 | High levels of serum glucose, insulin, leptin, C-peptide, glycated hemoglobin, GLP-1, liver injury markers, lipid profile in serum and liver in high-fructose-fed rats were significantly suppressed after Lr263 administration. Feeding of Lr263 reversed the decreased number of bifidobacterium species and lactobacillus species and increased number of clostridium species induced by high fructose treatment. |
…”